Efficacy of Quetiapine in Generalised Social Anxiety Disorder, a Double-blind, Placebo-controlled Study.

Trial Profile

Efficacy of Quetiapine in Generalised Social Anxiety Disorder, a Double-blind, Placebo-controlled Study.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 26 Jan 2011

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Social phobia
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 05 Dec 2007 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 20 Nov 2007 Status changed from in progress to completed.
    • 05 Nov 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top